X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rheumatology (28) 28
index medicus (27) 27
humans (26) 26
male (25) 25
female (24) 24
adult (23) 23
adalimumab (21) 21
middle aged (17) 17
treatment outcome (17) 17
antirheumatic agents - therapeutic use (16) 16
double-blind method (16) 16
severity of illness index (13) 13
abridged index medicus (12) 12
double-blind (12) 12
rheumatoid arthritis (12) 12
ankylosing-spondylitis (11) 11
safety (10) 10
disease-activity (9) 9
placebo-controlled trial (9) 9
aged (8) 8
ankylosing spondylitis (8) 8
rheumatoid-arthritis (8) 8
spondylarthritis - drug therapy (8) 8
tumor necrosis factor-tnf (8) 8
antibodies, monoclonal, humanized - therapeutic use (7) 7
arthritis, rheumatoid - drug therapy (7) 7
etanercept (7) 7
inflammation (7) 7
infliximab (7) 7
methotrexate (7) 7
musculoskeletal diseases (7) 7
time factors (7) 7
combination (6) 6
patients (6) 6
spondylitis, ankylosing - drug therapy (6) 6
spondyloarthritis (6) 6
therapy (6) 6
tnf inhibitors (6) 6
adalimumab - therapeutic use (5) 5
anti-tnf (5) 5
antirheumatic agents - adverse effects (5) 5
arthritis (5) 5
care and treatment (5) 5
clinical trials (5) 5
criteria (5) 5
dose-response relationship, drug (5) 5
drug dosages (5) 5
efficacy (5) 5
infections (5) 5
psoriatic-arthritis (5) 5
quality of life (5) 5
society classification criteria (5) 5
spondylarthritis - diagnosis (5) 5
studies (5) 5
tumor necrosis factor-alpha - antagonists & inhibitors (5) 5
1506 (4) 4
american-college (4) 4
arthritis, rheumatoid - physiopathology (4) 4
axial spondyloarthritis (4) 4
back pain (4) 4
classification (4) 4
disease control (4) 4
disease progression (4) 4
disease-activity score (4) 4
drug therapy, combination (4) 4
magnetic resonance imaging (4) 4
methotrexate - therapeutic use (4) 4
outcomes (4) 4
skin cancer (4) 4
spondylarthritis (4) 4
tofacitinib (4) 4
activity score asdas (3) 3
analysis (3) 3
antibodies, monoclonal, humanized (3) 3
antibodies, monoclonal, humanized - adverse effects (3) 3
antirheumatic agents - administration & dosage (3) 3
antitumor necrosis factor (3) 3
baricitinib (3) 3
c-reactive protein (3) 3
clinical and epidemiological research (3) 3
clinical science (3) 3
disease (3) 3
disease activity (3) 3
follow-up studies (3) 3
health status (3) 3
health-related quality of life (3) 3
herpes zoster (3) 3
improvement (3) 3
janus kinase (3) 3
magnetic resonance imaging - methods (3) 3
medical research (3) 3
medicine and health sciences (3) 3
medicine, general & internal (3) 3
methotrexate - administration & dosage (3) 3
pharmaceutical industry (3) 3
prognosis (3) 3
proteins (3) 3
radiographic progression (3) 3
research consortium (3) 3
respiratory tract (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Rheumatology, ISSN 0315-162X, 12/2018, Volume 45, Issue 12, pp. 1628 - 1635
Objective. Obese patients with rheumatoid arthritis (RA) report more joint swelling and tenderness and often have poorer responses to therapy than nonobese... 
Obesity | Adalimumab | Methotrexate | Rheumatoid arthritis | POPULATION | IMMUNE CELLS | ADALIMUMAB | INITIATION | COMBINATION THERAPY | METHOTREXATE | RHEUMATOLOGY | OBESITY | PHARMACOKINETICS | ULTRASOUND | RHEUMATOID ARTHRITIS | BODY-MASS INDEX | ASSOCIATION | PROGRESSION | ADIPOSE-TISSUE
Journal Article
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2016, Volume 68, Issue 12, pp. 2867 - 2877
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 12/2016, Volume 68, Issue 12, pp. 2857 - 2866
Journal Article
The Lancet, ISSN 0140-6736, 06/2018, Volume 391, Issue 10139, pp. 2513 - 2524
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.